EcoDrugPlus

Progesterone Receptor-Like

Ensembl ID : ENSOKIG00005037614
Gene Symbol: LOC109876091
2 Cross references
199 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSOKIG00005039224
Gene Symbol: PTGDR2
3 Cross references
141 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSOKIG00005002482
Gene Symbol: PTGDR2
3 Cross references
130 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSOKIG00005034705
Gene Symbol: PTGDR2
1 Cross references
130 Possible Orthologues:

Prostaglandin E Receptor 1a (Subtype Ep1)

Ensembl ID : ENSOKIG00005008328
Gene Symbol: PTGER1A
1 Cross references
162 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSOKIG00005012111
Gene Symbol: PTGER2A
1 Cross references
196 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSOKIG00005044179
Gene Symbol: PTGER3
3 Cross references
195 Possible Orthologues:

Prostaglandin E Receptor 4 (Subtype Ep4) B

Ensembl ID : ENSOKIG00005028779
Gene Symbol: PTGER4B
1 Cross references
195 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype

Ensembl ID : ENSOKIG00005008306
Gene Symbol: LOC109877489
3 Cross references
161 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype

Ensembl ID : ENSOKIG00005013767
Gene Symbol: LOC109892270
3 Cross references
158 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSOKIG00005009429
Gene Symbol: LOC109893440
3 Cross references
159 Possible Orthologues:

Prostaglandin E2 Receptor Ep2 Subtype

Ensembl ID : ENSOKIG00005033462
Gene Symbol: LOC109866514
3 Cross references
163 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).